Bio-Rad Laboratories, Inc.BIONYSE
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR-20.0%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-20.0%/yr
Quarterly compound
Percentile
P85
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 310.59% |
| Q3 2025 | -207.58% |
| Q2 2025 | 396.56% |
| Q1 2025 | 108.94% |
| Q4 2024 | -209.59% |
| Q3 2024 | 130.16% |
| Q2 2024 | -664.05% |
| Q1 2024 | 9.78% |
| Q4 2023 | 229.12% |
| Q3 2023 | 109.14% |
| Q2 2023 | -1785.35% |
| Q1 2023 | -91.73% |
| Q4 2022 | 607.51% |
| Q3 2022 | 82.29% |
| Q2 2022 | 72.47% |
| Q1 2022 | -113.98% |
| Q4 2021 | -140.06% |
| Q3 2021 | 329.71% |
| Q2 2021 | -6.48% |
| Q1 2021 | 16.48% |
| Q4 2020 | -36.18% |
| Q3 2020 | 36.05% |
| Q2 2020 | 40.90% |
| Q1 2020 | 23.93% |
| Q4 2019 | 313.85% |
| Q3 2019 | -143.22% |
| Q2 2019 | -30.79% |
| Q1 2019 | 203.85% |
| Q4 2018 | -409.35% |
| Q3 2018 | 0.48% |
| Q2 2018 | -59.19% |
| Q1 2018 | 839.60% |
| Q4 2017 | 155.17% |
| Q3 2017 | 444.05% |
| Q2 2017 | -59.44% |
| Q1 2017 | 160.35% |
| Q4 2016 | -211.76% |
| Q3 2016 | 2.17% |
| Q2 2016 | 46.74% |
| Q1 2016 | -75.19% |